Functional, phenotypic and molecular characterization of cytokine low- responding circulating CD34+ haemopoietic progenitors

British Journal of Haematology

Volumn 102, Issue 5, 1998, Pages 1139-1150

  Pierelli, Luca ^a   Scambia, Giovanni ^a   Fattorossi, Andrea ^a   Bonanno, Giuseppina ^a   Battaglia, Alessandra ^a   Rumi, Carlo ^a   Marone, Maria ^a   Mozzetti, Simona ^a   Rutella, Sergio ^a   Menichella, Giacomo ^a   Romeo, Virgilio ^a   Mancuso, Salvatore ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bcl 2; CD105; CFDA SE; Circulating CD34+ cells

Indexed keywords

CD34 ANTIGEN; CYTOKINE;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL SURVIVAL; FLOW CYTOMETRY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MOLECULAR CLONING; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

ANTIGENS, CD; ANTIGENS, CD34; CELL CYCLE; CELL DIVISION; CYTOKINES; FEMALE; FLUORESCEINS; FLUORESCENT DYES; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOPHENOTYPING; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; SUCCINIMIDES; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 7344233740     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00885.x     Document Type: Article

References (34)

1. Andrews, R.G., Singer, J.W. & Bernstein, I.D. (1989) Precursors of colony-forming cells in human can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. Journal of Experimental Medicine, 169, 1721-1731.
2. Brandt, J.E., Baird, N., Lu, L., Srour, E. & Hoffman, R. (1988) Characterization of a human hematopoietic progenitor cells capable of forming cell containing colonies in vitro. Journal of Clinical Investigation, 82, 1017-1027.
3. Campos, L., Sabido, O., Rouault, J.-P. & Guyotat, D. (1994) Effects of bcl-2 antisense oligodexynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood, 84, 595-600.
4. Cheifetz, S., Bellòn, T., Calés, C., Vera, S., Bernabéu, C., Massagué, J. & Letarte, M. (1992) Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. Journal of Biological Chemistry, 267, 19027-19030.
5. de St Groth, S.F. (1982) The evaluation of limiting dilution assays. Journal of Immunological Methods, 49, R11-R23.
6. + subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets. Stem Cells, 14, 566-576.
7. Fattorossi, A., Pierelli, L., Scambia, G., Ciarli, M., Bonanno, G., Battaglia, A., Menichella, G., Benedetti Panici, G., Bizzi, B. & Mancuso, S. (1996) A multiparameter flow cytometric approach to hematopoietic differentiation in vitro. Cytometry, Suppl. 8, 79.
8. Ferlini, C., Biselli, R., Nisini, R. & Fattorossi, A. (1995) Rhodamine 123: a useful probe for monitoring T cell activation. Cytometry, 21, 284-293.
9. +CD38 cells in cord blood and bone marrow. Blood, 86, 3745-3753.
10. Hatzfeld, J., Li, M-L., Brown, E.L., Sookdeo, H., Levesque, J-P., O'Toole, T., Gurney, C., Clark, S.C. & Hatzfeld, A. (1991) Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotides. Journal of Experimental Medicine, 174, 925-929.
11. Hockenbery, D.M., Zutter, M., Hickey, W., Nahm, M. & Korsemeyer, S.J. (1991) Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proceedings of the National Academy of Sciences of the United States of America, 88, 6961-6965.
12. - hematopoietic stem cells. Blood, 83, 1515-1526.
13. + cells. Blood, 87, 949-955.
14. Lyons, A.B. & Parish, C.R. (1994) Determination of lymphocyte division by flow cytometry. Journal of Immunological Methods, 171, 131-137.
15. Marone, M., Scambia G., Mozzetti, S., Ferrandina, G., Iacovella, S., De Pasqua, A., Benedetti Panici, P. & Mancuso, S. (1998) bcl-2, bax, bcl-xL , and bcl-xS expression in normal and neoplastic ovarian tissues. Clinical Cancer Research, 4, 517-524.
16. Menichella, G., Pierelli, L., Scambia, G., Salerno, G., Benedetti Panici, P., Foddai M.L., Serafini, R., Puglia, G., Lai, M., Ciarli, M., Mancuso, S. & Bizzi, B. (1994) Low-dose cyclophosphamide in combination with cisplatin or epirubicin plus rhG-CSF allows adequate collection of PBSC for autotransplantation during adjuvant therapy for high-risk cancer. Bone Marrow Transplantation, 14, 907-912.
17. + progenitor cells from bone marrow and peripheral blood during G-CSF-enhanced recovery. Experimental Hematology, 23, 1535-1542.
18. + Lin subpopulation from mobilized peripheral blood. Blood, 85, 368-378.
19. - cell production in vitro. British Journal of Haematology, 98, 528-539.
20. Park, J.R., Bernstein, I.D. & Hockenbery, D.M. (1995) Primitive human hematopoietic precursors express Bcl-x but not Bcl-2. Blood, 86, 868-876.
21. + progenitors undergo selective erythroid differentiation in liquid culture in the presence of erythropoietin and stem cell factor. British Journal of Haematology, 96, 55-63.
22. +CD38) human bone marrow progenitors: distinct and key interactions with the ligands for c-kit and flt 3, and inhibitory effects of TGF-β and TNF-α. Journal of Immunology, 158, 5169-5177.
23. Reed, J.C. (1997) Double identity for protein of the BCL-2 family. Nature, 387, 387-389.
24. + peripheral blood progenitors are myeloperoxidase-negative and noncycling irrespective of CD33 or CDI3 coexpression. Experimental Hematology, 25, 246-251.
25. + bone marrow cells. Blood, 84, 1473-1481.
26. + cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens. Stem Cells, 15, 73-81.
27. Srour, E.F., Leemhuis, T., Brandt, J.E., vanBesien, K. & Hoffman, R. (1991) Simultaneous use of rhodamine 123, phycoerythrin, Texas red, and allophycocyanin for the isolation of human hematopoietic progenitor cells. Cytometry 12, 179-183.
28. Sutherland, H.J., Eaves, C.J., Lansdorp, P.M., Thacker, J.D. & Hogge, D.E. (1991) Differential regulation of primitive hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood, 78, 666-672.
29. - progenitor cells. Blood, 77, 1218-1227.
30. Traycoff, C.M., Kosak, S.T., Grigsby, S. & Srour, E. (1995) Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using cell tracking and limiting dilution analysis. Blood, 85, 2059-2068.
31. + human hematopoietic progenitors. Experimental Hematology, 24, 1509-1515.
32. + hematopoietic progenitor cells. Blood, 88, 2549-2558.
33. Yamamura Y., Rodriguez, H., Schwartz A., Eylar, E., Bagwell, B. & Yano, N. (1995) A new flow cytometric method for assessment of lymphocyte mitogenic potentials. Cellular und Molecular Biology, 41, (Suppl. 1), S121-S132.
34. Young, J.C., Varma, A., DiGiusto, D. & Backer, M.P. (1996) Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood, 87, 545-556.